AIM
MEDP icon

Acrospire Investment Management’s Medpace MEDP Stock Holding History

Acrospire Investment Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-400
Closed -$12K – 848
2017
Q2 		$12K Sell
400
-1,800
-82% -$50.5K 0.01% 1743
2017
Q1 		$66K Sell
2,200
-2,600
-54% -$83.9K 0.05% 689
2016
Q4 		$173K Buy
+4,800
New +$160K 0.07% 471

Other funds holding MEDP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCA
Bernzott Capital Advisors Camarillo, California $250M AUM 26.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acrospire Investment Management's MEDP Position: Q3 2017 in Review

Acrospire Investment Management sold out of Medpace (MEDP) in Q3 2017, closing a stake of 400 shares — an estimated $12K sold.

Acrospire Investment Management first reported a position in MEDP in Q4 2016 and held it in 3 quarters. The position peaked at $173K in Q4 2016. 86 funds tracked by Wall St. Rank hold MEDP as of Q3 2017.

  • Acrospire Investment Management reported no remaining Medpace position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 400 Medpace shares in Q3 2017, an estimated $12K.
  • Acrospire Investment Management first reported a position in Medpace in Q4 2016 and held it in 3 quarters.
  • Acrospire Investment Management's Medpace position peaked at $173K in Q4 2016.
  • 86 funds tracked by Wall St. Rank held Medpace as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.